Findings of APOE4 deleterious effects on COVID-19 outcomes have been identified in UK biobank studies enrolling patients living in developed settings; however, there is a gap of knowledge whether this potential effect could be replicated in populations living under adverse environments, as APOE4 could have a different role in such conditions (42–44). This evidence concerns the gene APOE and COVID-19.